Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06950008 · ClinicalTrials.gov registry record · NA

A Patient Navigation Intervention for the Improvement of Risk Management Among Women at High Risk of Breast Cancer

A NA study of Breast Carcinoma, sponsored by Ohio State University Comprehensive Cancer Center.

Recruiting
Registry status
NA
Development phase
75
Enrollment target
1
Study location

NCT06950008: Recruiting NA study of Breast Carcinoma, sponsored by Ohio State University Comprehensive Cancer Center.

NCT06950008 is a NA study of Breast Carcinoma that is actively recruiting participants, run by Ohio State University Comprehensive Cancer Center. The registered enrollment target is 75 participants, below the 770-participant average among 106 other Breast Carcinoma trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06950008, a NA study of Breast Carcinoma, is actively recruiting participants, sponsored by Ohio State University Comprehensive Cancer Center.

RECRUITING
Registry status
NA
Development phase
75 participants
Enrollment target
1
Study location

Study Summary

This clinical trial studies whether a patient navigation (PN) intervention can be used to improve risk management among women at high risk of breast cancer. Women with a family history of breast cancer have a higher lifetime risk of developing it. Risk management can benefit women at high risk of breast cancer and can include surveillance routines, preventative surgeries, and medications that can dramatically lower the risk of breast cancer and allow early detection. Although risk management can benefit women at high risk of breast cancer, only a small amount actually use it. PN is a healthcare service that is designed to guide a patient through the healthcare system and reduce barriers to timely screening, follow-up, diagnosis, treatment, and supportive care. The PN intervention in this study is designed to help give women the information and support they need to make choices about their breast cancer risk that they feel good about, which may improve risk management.

Primary Outcome

Will be measured using previously validated survey questions related to patient navigation interactions. Will be defined as at least 50% of intervention arm participants are "satisfied" or "very satisfied" with the PN intervention. Will be formally assessed using a point estimate and 95% one-sided (score-based) confidence interval.

Conditions Studied

Interventions

  • OTHER Survey Administration
  • OTHER Educational Intervention
  • BEHAVIORAL Patient Navigation
  • BEHAVIORAL Telephone-Based Intervention

Study Locations (1)

Ohio

  • Ohio State University Comprehensive Cancer Center - Columbus

Trial Details

FieldValue
Enrollment Target 75 participants
Start Date 2026-01-10
Est. Completion 2026-12-31
Phase NA

What NCT06950008 shows while recruiting

NCT06950008 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 75 participants, a relatively small participant target, below the 770-participant average among 106 other Breast Carcinoma trials with a reported enrollment target (90% lower).

The record links to 1 condition, with Breast Carcinoma appearing as the primary indexed condition, and to 4 interventions - of which Survey Administration is the first listed.

NCT06950008 reports a single indexed study location in Ohio.

Frequently Asked Questions

What is clinical trial NCT06950008 about?

NCT06950008 is a clinical study titled "A Patient Navigation Intervention for the Improvement of Risk Management Among Women at High Risk of Breast Cancer". This clinical trial studies whether a patient navigation (PN) intervention can be used to improve risk management among women at high risk of breast cancer. Women with a family history of breast cancer have a higher lifetime risk of developing it. Risk management can benefit women at high risk of br...

What is the current status of trial NCT06950008?

This trial is currently recruiting. It is a NA study. The enrollment target is 75 participants. The study started on 2026-01-10. Estimated completion is 2026-12-31.

What conditions does trial NCT06950008 study?

This clinical trial studies the following conditions: Breast Carcinoma.

What interventions are being tested in trial NCT06950008?

The interventions under investigation include: Survey Administration (OTHER), Educational Intervention (OTHER), Patient Navigation (BEHAVIORAL), Telephone-Based Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT06950008?

This trial is sponsored by Ohio State University Comprehensive Cancer Center, which has 341 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06950008 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Breast Carcinoma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06950008's enrollment target sits among peer trials

75 70th of 106 higher than 37 of 106 other Breast Carcinoma trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Breast Carcinoma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01535430 · 75 participants

    Assessment of Eloquent Function in Brain Tumor Patients

  • NCT01542879 · 75 participants · Phase 1

    Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer

  • NCT02232191 · 75 participants · Phase 2

    Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients

  • NCT02754544 · 75 participants · NA

    Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06950008, the US trial registry maintained by the National Library of Medicine. NCT06950008 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.